Medico Remedies Limited

NSE MEDICO.NS

Medico Remedies Limited Operating Income Margin for the year ending March 31, 2024: 7.01%

Medico Remedies Limited Operating Income Margin is 7.01% for the year ending March 31, 2024, a 42.76% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Medico Remedies Limited Operating Income Margin for the year ending March 31, 2023 was 4.91%, a 12.80% change year over year.
Medico Remedies Limited Operating Income Margin for the year ending March 31, 2022 was 4.36%, a 48.50% change year over year.
Medico Remedies Limited Operating Income Margin for the year ending March 31, 2021 was 2.93%, a 119.10% change year over year.
Medico Remedies Limited Operating Income Margin for the year ending March 31, 2020 was 1.34%, a 4.47% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

NSE: MEDICO.NS

Medico Remedies Limited

CEO	Mr. Haresh Kapurlal Mehta
IPO Date	May 26, 2022
Location	India
Headquarters	1105/1106, Hubtown Solaris
Employees	193
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Key trends

Past 5 years